Security key
282564103
Eikon Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EIKN)
CUSIP: 282564103
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 23,743,113
- Total 13F value
- $251,203,493
- Share change
- +22,614,368
- SEC-reported price per share
- $10.58
- Number of holders
- 52
- Value change
- +$239,261,371
- Number of buys
- 48
- Shares outstanding
- 54,464,520
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
52
Top holders
10
EIKN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Eikon Therapeutics, Inc. SEC filings
Eikon Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 282564103
Recent filing periods:
Ownership snapshot
Top reported holders of EIKN - Eikon Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Column Group IV GP, LP
Disclosed value leader
Column Group IV GP, LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 12%
13D/G row: Column Group IV GP, LP
Showing 1-6 of 15 holder rows.
Quick read
Column Group IV GP, LP leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Column Group IV GP, LP's linked filing trail.
Comparable ownership
Top 5
Column Group IV GP, LP
12%
Foresite Capital Fund IV, L.P.
7.7%
FMR LLC
7.1%
BlackRock Portfolio Management LLC
5.5%
Roger M. Perlmutter
5.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Column Group IV GP, LP |
13D/G
3/4/5
Tim Kutzkey · 10%+ Owner
|
12%
|
$131,204,153
6,353,712 shares
|
$0 | 06 Feb 2026 |
| Foresite Capital Fund IV, L.P. |
13D/G
James B. Tananbaum
|
7.7%
|
—
4,148,519 shares
|
$0 | 04 Feb 2026 |
| FMR LLC |
13D/G
|
7.1%
|
$37,869,512
3,836,830 shares
|
$0 | 31 Mar 2026 |
| BlackRock Portfolio Management LLC |
13D/G
|
5.5%
|
$29,456,850
3,002,737 shares
|
$0 | 31 Mar 2026 |
| Roger M. Perlmutter |
13D/G
3/4/5
PERLMUTTER ROGER M · Chief Executive Officer and Director, Director
|
5.2%
|
$28,555,598
2,893,171 shares
|
$0 | 04 Feb 2026 |
| Abu Dhabi Investment Authority |
13D/G
|
5.2%
|
—
2,816,714 shares
|
$0 | 04 Feb 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
52
Shares
23,743,113
Rows available
52
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
52
Q1 2026 holders
52
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend